Cargando…
The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example
BACKGROUND: Studies evaluating the effects of cancer treatments are prone to immortal time bias that, if unaddressed, can lead to treatments appearing more beneficial than they are. METHODS: To demonstrate the impact of immortal time bias, we compared results across several analytic approaches (dich...
Autores principales: | Duchesneau, Emilie D., Jackson, Bradford E., Webster-Clark, Michael, Lund, Jennifer L., Reeder-Hayes, Katherine E., Nápoles, Anna M., Strassle, Paula D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627261/ https://www.ncbi.nlm.nih.gov/pubmed/35984990 http://dx.doi.org/10.1158/1055-9965.EPI-22-0495 |
Ejemplares similares
-
Response to letter, ‘Immortal time bias in retrospective analysis'
por: Dimopoulos, M A, et al.
Publicado: (2015) -
Preventing immortal time bias in observational studies: a matter of design
por: Velders, Bart J J, et al.
Publicado: (2023) -
Reply to: Immortal time bias in the analysis of drug prescription trajectories
por: Mortensen, Laust Hvas, et al.
Publicado: (2022) -
Matters Arising: Immortal time bias in the analysis of drug prescription trajectories
por: Christensen, Daniel Mølager, et al.
Publicado: (2022) -
Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
por: Suissa, Samy, et al.
Publicado: (2022)